Trials / Completed
CompletedNCT00513487
Effects of Multiple Nasal Exposures to House Dust Mite Allergen on Nasal and Body Inflammation and Airway Sensitivity
Assessment of the Effects of Multiple Nasal Antigen Challenges With Dust Mite Allergen on Local and Systemic Allergic Inflammation and Bronchoreactivity in Subjects With Allergic Rhinitis Sensitive to House Dust Mite - a Feasibility and Site Evaluation Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 18 (estimated)
- Sponsor
- Novartis · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This study will evaluate whether multiple nasal antigen challenges with dust mite allergen produces increases in nasal symptoms and local allergic inflammatory cells in the nose and the blood.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dust mite extract, Fluticasone, Methacholine | Dust mite extract, Fluticasone, Methacholine |
Timeline
- Start date
- 2007-07-01
- Completion
- 2007-11-01
- First posted
- 2007-08-08
- Last updated
- 2008-07-15
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT00513487. Inclusion in this directory is not an endorsement.